The Nerve Repair and Regeneration Market is Expected to Reach USD 10.59 Billion by 2022

Manish Arya / On 2017-11-11 05:27:47

According to a new market research report "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices - Global Forecast to 2022", published by MarketsandMarkets™, the Market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%.

On the basis of neurostimulation and neuromodulation device product is sub segmented into internal neurostimulation device and external neurostimulation device. The internal neurostimulation device segment is expected to account for the largest share of this market in 2017. This growth can be attributed to minimally invasive techniques and increasing number of people suffering from back surgery syndrome which drives this segment.

In the end user, the nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market. The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.

By region, the global nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017, Asia is expected to register the highest CAGR during the forecast period. The presence of emerging economies like China and India; the large population; growth in the number of hospitals, and increasing neurological disorder in the region are some major factors driving the high growth of this regional segment.
Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).

The report segments this market based on product, application, end user, and region. The market study covers the global nerve repair and regeneration market from 2015 to 2022 and provides details of the factors influencing the market at both macro and micromarket. The report also provides a detailed overview of the major drivers, opportunities, restrains, current market challenges, and strategies impacting the nerve repair and regeneration market along with the estimates and forecasts of the revenue and market share analysis.

Related Stories